Hypofractionation in COVID-19 radiotherapy: A mix of evidence based medicine and of opportunities.

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

Who cites it

14 citing papers in PubMed.

1. Adoption of Hypofractionated and Ultrahypofractionated Adjuvant Radiation Therapy for Breast Cancer Across Main and Community Centers Within a Single Healthcare System.Current oncology (Toronto, Ont.) · 2025
   Article
2. Nursing Care for Metastatic Bone Cancer: Trends for the Future.International journal of environmental research and public health · 2023
   Article
3. Defining Radiation Treatment Interruption Rates During the COVID-19 Pandemic: Findings From an Academic Center in an Underserved Urban Setting.International journal of radiation oncology, biology, physics · 2023
   Article
4. Impact of the COVID-19 pandemic on Radiation Therapy Practice: A Catalyst for Research.Radiography (London, England : 1995) · 2022
   Article
5. Impact of the First Wave of COVID-19 Pandemic on Radiotherapy Practice at Tata Memorial Centre, Mumbai: A Longitudinal Cohort Study.JCO global oncology · 2022
   Article
6. Longitudinal in-vivo quantification of tumour microvascular heterogeneity by optical coherence angiography in pre-clinical radiation therapy.Scientific reports · 2022
   Article
7. Covid-19 and radiotherapy: a systematic review after 2 years of pandemic.Clinical and translational imaging · 2022
   Review
8. Elimination of cervical cancer as a public health problem-how shorter brachytherapy could make a difference during COVID-19.Ecancermedicalscience · 2022
   Article
9. New Challenges of Treatment for Locally Advanced Head and Neck Cancers in the Covid-19 Pandemic Era.Journal of clinical medicine · 2021
   Review
10. Novel coronavirus mitigation measures implemented by radiotherapy centres in low and middle-income countries: a systematic review.Reports of practical oncology and radiotherapy : journal of Greatpoland Cancer Center in Poznan and Polish Society of Radiation Oncology · 2021
    Review
11. Back to (new) normality-A CODRAL/AIRO-L survey on cancer radiotherapy in Lombardy during Italian COVID-19 phase 2.Medical oncology (Northwood, London, England) · 2020
    Article
12. Two months of radiation oncology in the heart of Italian "red zone" during COVID-19 pandemic: paving a safe path over thin ice.Radiation oncology (London, England) · 2020
    Article
13. Prostate brachytherapy utilization in the COVID-19 era: A cross-sectional study of radiation oncologists in the United States.Brachytherapy
    Article
14. Trends in Radiation Oncology Treatment Fractionation at a Single Academic Center, 2010 to 2020.Advances in radiation oncology
    Article

Corrections and comments

• Comment on
  Southern Italy: How the Availability of Radiation Therapy, Patient Outcomes, and Risk to Health Care Providers Have Changed During the Coronavirus Disease 2019 Pandemic.

Authors and funding

6 authors.

Funding

No grant is acknowledged in the PubMed record.

Abstract

PubMed holds no abstract for this paper.